Skip to main content

Peer Review reports

From: Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada

Original Submission
27 Sep 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Oct 2023 Reviewed Reviewer Report
30 Oct 2023 Reviewed Reviewer Report - Jaden Brandt
12 Jan 2024 Author responded Author comments - Dean T. Eurich
Resubmission - Version 4
12 Jan 2024 Submitted Manuscript version 4
15 Jan 2024 Author responded Author comments - Dean T. Eurich
Resubmission - Version 5
15 Jan 2024 Submitted Manuscript version 5
27 Jan 2024 Reviewed Reviewer Report - Jaden Brandt
31 Jan 2024 Reviewed Reviewer Report
14 Feb 2024 Author responded Author comments - Dean T. Eurich
Resubmission - Version 6
14 Feb 2024 Submitted Manuscript version 6
8 Mar 2024 Reviewed Reviewer Report
13 Mar 2024 Reviewed Reviewer Report - Jaden Brandt
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
14 Mar 2024 Editorially accepted
20 Mar 2024 Article published 10.1186/s12889-024-18356-6

You can find further information about peer review here.

Back to article page